Clinical data links oral bisphosphonates to increased jaw necrosis. The study is among the first to acknowledge that even short-term use of common oral osteoporosis drugs may leave the jaw vulnerable to devastating necrosis. Fosomax is the most widely prescribed oral bisphosphonate.